Literature DB >> 22994803

Bleeding disorders, menorrhagia and iron deficiency: impacts on health-related quality of life.

C Rae1, W Furlong, J Horsman, E Pullenayegum, C Demers, J St-Louis, D Lillicrap, R Barr.   

Abstract

von Willebrand disease (VWD) is a bleeding disorder that occurs in up to 1% of the general population. The great majority of females with VWD experience menorrhagia. The morbidity burden in females with VWD may relate to iron deficiency resulting from menorrhagia. To explore relationships between bleeding disorders, menorrhagia, iron deficiency and the outcomes of health-related quality of life (HRQL) and educational attainment. All subjects with VWD, and females with other bleeding disorders, in the Canadian national registry who were more than 12 years of age were eligible for survey. Survey measures included the HEALTH UTILITIES INDEX(®); abridged Clinical History Assessment Tool; socio-demographic questions and serum ferritin. Statistical analyses included testing differences among groups of means using analysis of variance and of proportions using chi-squared test. Significant size differences in mean HRQL scores were detected between VWD females and both females with other bleeding disorders [diff = (-0.08); P = 0.017] and VWD males [diff = (-0.07); P = 0.039]. Mean HRQL scores differed between females with and without menorrhagia (P < 0.001). Mean HRQL scores were not significantly different between females with and without iron deficiency. Educational attainment was not associated with disease group, menorrhagia status or iron status. Females with VWD have a greater morbidity burden than females in the general population, females with other bleeding disorders and males with VWD. Menorrhagia is associated with low HRQL scores in females with bleeding disorders, including VWD. Further investigation should assess how menorrhagia impacts HRQL in females with bleeding disorders.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22994803      PMCID: PMC4171051          DOI: 10.1111/hae.12014

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  30 in total

1.  Willingness to pay in treatment of bleeding disorders.

Authors:  S R Eastaugh
Journal:  Int J Technol Assess Health Care       Date:  2000       Impact factor: 2.188

2.  Multiattribute and single-attribute utility functions for the health utilities index mark 3 system.

Authors:  David Feeny; William Furlong; George W Torrance; Charles H Goldsmith; Zenglong Zhu; Sonja DePauw; Margaret Denton; Michael Boyle
Journal:  Med Care       Date:  2002-02       Impact factor: 2.983

3.  Health status and health-related quality of life associated with hemophilia.

Authors:  Ronald D Barr; Mahassen Saleh; William Furlong; John Horsman; Julia Sek; Mohan Pai; Irwin Walker
Journal:  Am J Hematol       Date:  2002-11       Impact factor: 10.047

Review 4.  The neurochemical basis of cognitive deficits induced by brain iron deficiency: involvement of dopamine-opiate system.

Authors:  M B Youdim; S Yehuda
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2000-05       Impact factor: 1.770

5.  von Willebrand disease and bleeding in women.

Authors:  M V Ragni; F A Bontempo; A C Hassett
Journal:  Haemophilia       Date:  1999-09       Impact factor: 4.287

6.  Clinical severity of disease, functional disability and health-related quality of life. Three-year follow-up study of 150 Finnish patients with coagulation disorders.

Authors:  S Solovieva
Journal:  Haemophilia       Date:  2001-01       Impact factor: 4.287

7.  Dietary and supplement treatment of iron deficiency results in improvements in general health and fatigue in Australian women of childbearing age.

Authors:  A J Patterson; W J Brown; D C Roberts
Journal:  J Am Coll Nutr       Date:  2001-08       Impact factor: 3.169

8.  Quality of life in women with bleeding disorders.

Authors:  S Von Mackensen
Journal:  Haemophilia       Date:  2011-07       Impact factor: 4.287

9.  von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.

Authors:  J A Dean; V S Blanchette; M D Carcao; A M Stain; C R Sparling; J Siekmann; P L Turecek; D Lillicrap; M L Rand
Journal:  Thromb Haemost       Date:  2000-09       Impact factor: 5.249

10.  Gynaecological and obstetrical morbidity in women with type I von Willebrand disease: results of a patient survey.

Authors:  P A Kouides; P D Phatak; P Burkart; C Braggins; C Cox; Z Bernstein; L Belling; P Holmberg; W MacLaughlin; F Howard
Journal:  Haemophilia       Date:  2000-11       Impact factor: 4.287

View more
  16 in total

Review 1.  Advances in the diagnosis and treatment of Von Willebrand disease.

Authors:  Ruchika Sharma; Veronica H Flood
Journal:  Blood       Date:  2017-11-30       Impact factor: 22.113

2.  Depression and post-traumatic stress disorder in individuals with hereditary hemorrhagic telangiectasia: A cross-sectional survey.

Authors:  Shruti Chaturvedi; Marianne Clancy; Nicole Schaefer; Olalekan Oluwole; Keith R McCrae
Journal:  Thromb Res       Date:  2017-03-09       Impact factor: 3.944

3.  Heavy menstrual bleeding and health-associated quality of life in women with von Willebrand's disease.

Authors:  Igor Govorov; Lena Ekelund; Roza Chaireti; Petra Elfvinge; Margareta Holmström; Katarina Bremme; Miriam Mints
Journal:  Exp Ther Med       Date:  2016-03-10       Impact factor: 2.447

Review 4.  Advances in the diagnosis and treatment of Von Willebrand disease.

Authors:  Ruchika Sharma; Veronica H Flood
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

Review 5.  Women and bleeding disorders: diagnostic challenges.

Authors:  Paula D James
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

6.  Significant gynecological bleeding in women with low von Willebrand factor levels.

Authors:  Michelle Lavin; Sonia Aguila; Niall Dalton; Margaret Nolan; Mary Byrne; Kevin Ryan; Barry White; Niamh M O'Connell; Jamie M O'Sullivan; Jorge Di Paola; Paula D James; James S O'Donnell
Journal:  Blood Adv       Date:  2018-07-24

7.  Bleeding patterns in patients before and after diagnosis of von Willebrand disease: Analysis of a US medical claims database.

Authors:  Jonathan C Roberts; Lynn M Malec; Imrran Halari; Sarah A Hale; Abiola Oladapo; Robert F Sidonio
Journal:  Haemophilia       Date:  2021-11-10       Impact factor: 4.263

8.  Unnecessary Hysterectomy due to Menorrhagia and Disorders of Hemostasis: An Example of Overuse and Excessive Demand for Medical Services.

Authors:  Svetlana M Djukic; Danijela Lekovic; Nikola Jovic; Mirjana Varjacic
Journal:  Front Pharmacol       Date:  2016-12-23       Impact factor: 5.810

9.  A systematic review of methods to measure menstrual blood loss.

Authors:  Julia L Magnay; Shaughn O'Brien; Christoph Gerlinger; Christian Seitz
Journal:  BMC Womens Health       Date:  2018-08-22       Impact factor: 2.809

10.  Improving the Evaluation and Management of Abnormal Uterine Bleeding in Female Adolescents Presenting for Emergency Care.

Authors:  Allison G Close; Gina M Sequeira; Gerald T Montano; Lauren J Alessi; Meghan C McCormick; James D Cooper; Rebecca A Epperly; Noel S Zuckerbraun
Journal:  J Pediatr Adolesc Gynecol       Date:  2018-11-17       Impact factor: 1.814

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.